First Time Loading...

Human Metabolome Technologies Inc
TSE:6090

Watchlist Manager
Human Metabolome Technologies Inc Logo
Human Metabolome Technologies Inc
TSE:6090
Watchlist
Price: 650 JPY -0.61% Market Closed
Updated: May 1, 2024
Section:
 

Relative Value

The Relative Value of one Human Metabolome Technologies Inc stock under the Base Case scenario is 597.69 JPY. Compared to the current market price of 650 JPY, Human Metabolome Technologies Inc is Overvalued by 8%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
597.69 JPY
Overvaluation 8%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.9
P/S
P/S
Price to Sales
2.9
vs History
87
vs Industry
58
Median 3Y
3.3
Median 5Y
3.9
Industry
3.9
More Details
13.6
P/E
P/E
Price to Earnings
13.6
vs History
59
vs Industry
35
Median 3Y
16.1
Median 5Y
14.9
Industry
30.3
More Details
15
P/OCF
P/OCF
Price to OCF
15
vs History
40
vs Industry
38
Median 3Y
14.9
Median 5Y
14.7
Industry
23.2
More Details
32.6
P/FCFE
P/FCFE
Price to FCFE
32.6
vs History
40
vs Industry
19
Median 3Y
32.1
Median 5Y
28.5
Industry
26.9
More Details
2.2
P/B
P/B
Price to Book Value
2.2
vs History
91
vs Industry
48
Median 3Y
2.7
Median 5Y
3.4
Industry
2.5
More Details
2
EV/S
EV/S
Enterprise Value to Sales
2
vs History
87
vs Industry
66
Median 3Y
2.4
Median 5Y
3
Industry
3.8
More Details
3.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.1
vs History
85
vs Industry
73
Median 3Y
3.5
Median 5Y
4.3
Industry
7.7
More Details
9.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
9.4
vs History
64
vs Industry
43
Median 3Y
10.7
Median 5Y
10.6
Industry
16.8
More Details
13.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
13.3
vs History
53
vs Industry
38
Median 3Y
15.3
Median 5Y
13.6
Industry
22
More Details
10.2
EV/OCF
EV/OCF
Enterprise Value to OCF
10.2
vs History
43
vs Industry
42
Median 3Y
10.3
Median 5Y
10.1
Industry
21.1
More Details
19.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
19.5
vs History
27
vs Industry
30
Median 3Y
16.2
Median 5Y
11.9
Industry
27.6
More Details
3.4
EV/IC
EV/IC
Enterprise Value to IC
3.4
vs History
93
vs Industry
29
Median 3Y
4.8
Median 5Y
7.3
Industry
2.4
More Details

Multiples Across Competitors

Competitors Multiples
Human Metabolome Technologies Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Human Metabolome Technologies Inc
TSE:6090
3.8B JPY 2.9 13.6 9.4 13.3
US
Thermo Fisher Scientific Inc
NYSE:TMO
220.8B USD 5.2 37 22.8 33.4
US
Danaher Corp
NYSE:DHR
181.6B USD 4.2 22.6 16.4 20.2
US
IQVIA Holdings Inc
NYSE:IQV
41.8B USD 2.8 30.8 16.7 25.9
US
Agilent Technologies Inc
NYSE:A
40.2B USD 6 32.6 26 31.3
KR
Samsung Biologics Co Ltd
KRX:207940
55.6T KRW 15 64.8 34.2 49.2
CH
Lonza Group AG
SIX:LONN
36.8B CHF 5.5 56.3 19.3 28.4
US
Mettler-Toledo International Inc
NYSE:MTD
26.3B USD 7 33.4 23.4 26
US
West Pharmaceutical Services Inc
NYSE:WST
26.3B USD 8.9 44.5 30.3 36.3
IE
ICON PLC
NASDAQ:ICLR
24.6B USD 3 40.2 17.1 26.7
FR
Sartorius Stedim Biotech SA
PAR:DIM
18.7B EUR 6.9 73.5 31.7 52

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.